A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study-Reference-Cited by-同舟云学术

A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study

Published:2018 Issue:1 Volume:9 Page:92-99
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Meng Dong-Fang,Sun Rui,Peng Li-Xia,Huang You-Sheng,Yang Qin,Luo Dong-Hua,Hu Wei-Han,Xie Fang-Yun,Luo Wei,Zhao Chong,Guo Ling,Mai Hai-Qiang,Chen Ming-Yuan,Xie Ping,Zheng Li-Sheng,Yang Jun-Ping,Mei Yan,Qiang Yuan-Yuan,Xu Liang,Li Chang-Zhi,Huang Bi-Jun,Qian Chao-Nan,Sun Rui

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy;European Journal of Medical Research;2023-10-05

2. Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma;Frontiers in Oncology;2023-09-28

3. Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort;Journal of Chemotherapy;2023-05-21

4. Efficacy and safety of weekly versus triweekly cisplatin treatment concomitant with radiotherapy for locally advanced nasopharyngeal carcinoma: A systematic review and pooled analysis;Frontiers in Pharmacology;2023-01-05

5. Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis;Medicine;2022-12-30